vaccine

Singapore temporarily halts use of two flu vaccines after South Korea deaths

Singapore has temporarily halted the use of two influenza vaccines as a precaution after some people who received them in South Korea died, becoming among the first countries to publicly…

Read More Here

South Korea urges people to get flu vaccinations despite death tolls

South Korea urged citizens to get vaccinated against influenza and reduce the chances of an outbreak that coincides with the battle on the coronavirus, as it kicked off free inoculations…

Read More Here

Pharma manufacturing plans gear up as companies enter last lap of the Covid-19 vaccine race – Update

AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial on Monday or Tuesday, the…

Read More Here

Hungary looking to Russia, China for COVID-19 vaccine

Hungarian Prime Minister Viktor Orban's government has asked local health experts to look into the efficacy of COVID-19 vaccines developed by Russia and China for possible later purchases, Orban's chief…

Read More Here

South Korea medical association says flu vaccine programme should be suspended

South Korea's medical association said on Thursday the government should suspend a flu vaccine programme following the deaths of at least 13 people who received a shot in recent days.…

Read More Here

AstraZeneca COVID-19 vaccine trial Brazil volunteer dies but trial to continue

Brazilian health authority Anvisa said that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would…

Read More Here

Chinese vaccines have been given to 60,000 people worldwide

The New York Times reports that Chinese vaccines have been administered to 60,000 people in clinical trials, many of them around the world, and none of them have experienced any…

Read More Here

EU signs supply deal with J&J on potential COVID-19 vaccine

The European Commission said on Wednesday it had signed a contract on behalf of EU states with U.S. drugmaker Johnson & Johnson for the supply of 400 million doses of…

Read More Here

South Korea will press on with flu vaccinations, sees no link to deaths

South Korean health authorities said on Wednesday they would press on with a flu vaccine programme as there was no reason to believe the scheme was linked to a number…

Read More Here

U.S. trial of AstraZeneca COVID-19 vaccine may resume this week

AstraZeneca Plc's COVID-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Food and Drug Administration completed its review of a…

Read More Here

Brussels opts for English for COVID vaccines in the EU

COVID-19 vaccines should have labels and packages with information only in English, European Union regulators have agreed, loosening multilingual requirements that could slow the roll-out of shots in the continent.…

Read More Here

Malta: Covid-19 vaccine expected to arrive in January

Health Minister Chris Fearne said a Covid-19 vaccine should be administered to the entire country six months after it is issued. The government predicts that Malta should have an injection…

Read More Here

Most people would get a COVID-19 vaccine if their government or employer recommended it, poll shows

Most people would get a COVID-19 vaccine if their government or employer recommended it, results of a global poll showed on Tuesday, amid growing concerns about public distrust of the shots being developed at speed to end the pandemic. Some 71.5% of participants…

Read More Here

UK to back vaccine trials that deliberately infect patients with Covid-19

Britain said on Tuesday it would back "human challenge" trials, where young and healthy volunteers are deliberately infected with COVID-19, to accelerate the development of vaccines for the disease. The government…

Read More Here

Indonesian president warns not to rush vaccines amid halal concern

The president of the world's largest Muslim-majority nation, Joko Widodo, called on Monday for Indonesia not to rush the rollout of vaccines, citing concerns over public awareness about whether they…

Read More Here

UK hits out at reported Russian misinformation on Covid vaccine

British Foreign Secretary Dominic Raab said on Friday a reported Russian disinformation campaign to undermine COVID-19 vaccine trials was "reprehensible" at a time when countries should be coming together. "We…

Read More Here

Swiss to buy 5.3 mln doses of AstraZeneca COVID-19 vaccine

Switzerland signed a contract for up to 5.3 million doses of a potential COVID-19 vaccine being developed and tested by AstraZeneca and Oxford University, the Swiss government said on Friday.…

Read More Here

Sinovac coronavirus vaccine offered by Chinese city for emergency use costs $60

A Chinese city is offering Sinovac Biotech's experimental COVID-19 vaccine to essential workers and other high-risk groups as part of a national programme for about $60. The eastern city of…

Read More Here

Britain moves closer to COVID-19 vaccine trials that infect volunteers

"Human challenge" trials of potential COVID-19 vaccines, where volunteers are deliberately infected with the disease, could become a reality after a British biotech firm signed a contract with the government…

Read More Here

WHO warns young people may not get vaccine until 2022

World Health Organization’s chief scientist, Soumya Swaminathan, has indicated that young, healthy people may have to wait until 2022 to get a vaccine and, that a despite the many vaccine…

Read More Here

Britain’s spies defending COVID-19 vaccine work

British spies are trying to defend COVID-19 vaccine work against hostile powers that seek to either steal or sabotage research data in the race for the global prize of a…

Read More Here

U.S. CDC says children may not be recommended for COVID-19 vaccination initially

The U.S. Centers for Disease Control and Prevention (CDC) said that COVID-19 vaccines may not be initially recommended for children, when they become available. Children, who rarely have severe COVID-19…

Read More Here

UK vaccines chief says first vaccines ‘unlikely to end pandemic’

The first wave of COVID-19 vaccines are unlikely to end the pandemic, the UK vaccines chief has told Sky News. The UK has 340 million doses of six prototype vaccines…

Read More Here

Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 ‘cure’ over safety concern

Eli Lilly and Co said that the government-sponsored clinical trial of its COVID-19 antibody treatment similar to one taken by U.S. President Donald Trump has been paused because of a…

Read More Here

WHO says that more than 180 countries committed to vaccine effort

More than 180 countries have committed to participate in the World Health Organization's (WHO) effort to finance COVID-19 vaccines to be distributed fairly to both rich and poor countries, the…

Read More Here

Johnson & Johnson pause Covid-19 vaccine clinical trials due to unexplained illness in study participant

Johnson and Johnson said on Monday it had temporarily paused its COVID-19 vaccine candidate clinical trials due to an unexplained illness in a study participant, delaying one of the highest…

Read More Here

Russia expected to register second COVID-19 vaccine on October 15

Russia is expected to register a second potential vaccine against COVID-19 on Oct. 15, the vaccine's developer said on Friday. The vaccine has been developed by Siberia's Vector Institute, which…

Read More Here

China joins COVAX initiative for COVID-19 vaccine distribution

China said on Friday it has joined a global COVID-19 vaccine initiative co-led by the World Health Organization (WHO), becoming the biggest economy to date to pledge support to help…

Read More Here

UPDATED: EU seals supply deal with Johnson & Johnson on COVID-19 vaccine

The European Commission said on Thursday it had sealed a supply deal with Johnson & Johnson for the supply of its potential COVID-19 vaccine for up to 400 million people.…

Read More Here

AstraZeneca could profit from COVID-19 vaccine as early as July

AstraZeneca could start profiting from its COVID-19 vaccine as soon as July next year, the Financial Times reported, citing a memo showing the British drugmaker can declare when it considers…

Read More Here

China’s experimental COVID-19 vaccine appears safe – study

A Chinese experimental coronavirus vaccine being developed by the Institute of Medical Biology under the Chinese Academy of Medical Sciences was shown to be safe in an early stage clinical…

Read More Here

COVID-19 vaccine may be ready by year-end – WHO

A vaccine against COVID-19 may be ready by year-end, the head of the World Health Organization (WHO) said on Tuesday, without elaborating. WHO Director-General Tedros Adhanom Ghebreyesus called for solidarity and political commitment by all leaders to ensure…

Read More Here

AstraZeneca resumes vaccine trial in Japan, in talks with U.S

AstraZeneca Plc said on Friday clinical trials of its experimental COVID-19 vaccine resumed in Japan, while adding that it was in talks with regulators on data needed to restart studies…

Read More Here

French Pasteur Institute aims to start human trials of Covid-19 drug this winter

The Pasteur Institute in the northern French city of Lille has confirmed the discovery of a “very promising” drug in the fight against the coronavirus pandemic, without naming it. As infection rates…

Read More Here

Europe lays ground for fast-tracking COVID-19 vaccine reviews

The European health regulator has started reviewing data on AstraZeneca and Oxford University's potential COVID-19 vaccine in real time, the first of such moves aimed at speeding up any approval…

Read More Here

British scientists warn that vaccine will ‘not return life to normal in spring’

Even an effective coronavirus vaccine will not return life to normal in spring, a group of leading scientists has warned. A vaccine is often seen as the holy grail that…

Read More Here

FDA widens U.S. safety inquiry into AstraZeneca coronavirus vaccine

The U.S. Food and Drug Administration has broadened its investigation of a serious illness in AstraZeneca Plc's COVID-19 vaccine study and will look at data from earlier trials of similar…

Read More Here

Moderna says COVID-19 vaccine unlikely to be ready before November

Moderna Inc will not be ready to apply for emergency authorization for its potential COVID-19 vaccine before the U.S. presidential election in November, the Financial Times reported on Wednesday, citing…

Read More Here

CureVac plans global late-stage COVID-19 vaccine trial

Germany's CureVac NV said it has started a mid-stage study testing its experimental coronavirus vaccine and plans to begin a decisive global trial with about 30,000 volunteers in the fourth…

Read More Here

World Bank seeks board approval for $12 bln coronavirus vaccine financing plan

World Bank President David Malpass said he is seeking board approval for a $12 billion coronavirus vaccine financing plan to help poor and developing countries secure a sufficient share of…

Read More Here

Novartis CEO says it will take more than vaccines to fight COVID

Vaccines alone will not be enough to fight Covid-19, Novartis AG Chief Executive Officer Vas Narasimhan said. Treatments will also play a crucial role. Significant supplies of highly effective vaccines…

Read More Here

GlaxoSmithKline CEO optimistic COVID-19 vaccine widely available in 2021

The chief executive of GlaxoSmithKline, the world's largest maker of vaccines, said she was optimistic the industry will be able to make an immunisation against COVID-19 widely available next year.…

Read More Here

Study shows Moderna COVID-19 vaccine appears safe, shows signs of working in older adults

Results from an early safety study of Moderna Inc's coronavirus vaccine candidate in older adults showed that it produced virus-neutralizing antibodies at levels similar to those seen in younger adults,…

Read More Here

Indian PM pledges to UN that country’s vaccine will be made available globally

Indian Prime Minister Narendra Modi pledged at the United Nations on Saturday that his country's vaccine production capacity would be made available globally to fight the COVID-19 crisis. "As the…

Read More Here

Johnson & Johnson COVID-19 vaccine produces strong immune response in early trial

A single dose of Johnson & Johnson's experimental COVID-19 vaccine produced a strong immune response against the novel coronavirus in an early-to-mid stage clinical trial, according to interim results published…

Read More Here

China says WHO gave blessing for coronavirus vaccine emergency use programme

The World Health Organization gave China its support and understanding to start administering experimental coronavirus vaccines to people while clinical trials were still underway, a Chinese health official said on…

Read More Here

AstraZeneca gets partial immunity in low-cost EU vaccine deal

European governments will pay claims above an agreed limit against AstraZeneca over side-effects from its potential COVID-19 vaccine, under different terms to a deal struck with Sanofi, an EU official…

Read More Here

Pfizer partner BioNTech sees no role for its vaccine in UK challenge trial

Pfizer's German development partner BioNTech on Thursday joined other leading COVID-19 vaccine developers in ruling out participation in British plans to test experimental inoculations by deliberately infecting trial volunteers. "BioNTech's…

Read More Here

Russia to supply 17 more countries with COVID-19 drug Avifavir

Russia's sovereign wealth fund and its partner Chemrar will supply the COVID-19 drug Avifavir to 17 additional countries, the fund said in a statement on Thursday. Avifavir gained approval from…

Read More Here

UK volunteers to be deliberately infected with COVID-19 to test vaccine

Britain is planning to host clinical trials where volunteers are deliberately infected with the new coronavirus to test the effectiveness of vaccine candidates, the Financial Times reported on Wednesday, citing…

Read More Here

EU close to concluding preliminary talks with Novavax on COVID vaccine supply

Brussels is close to wrapping up preliminary talks with U.S. vaccine maker Novavax for its potential COVID-19 shot, an EU source involved in the negotiations said, as the bloc ramps…

Read More Here

U.S. FDA to tighten coronavirus vaccine authorization standards ahead of election

The U.S. Food and Drug Administration is expected to soon announce new, more stringent standards for an emergency authorization of a COVID-19 vaccine, lowering the chances that one might be…

Read More Here

Moderna sees 20 million doses of COVID-19 vaccine candidate by year end

Moderna Inc announced it was on track to produce 20 million doses of its experimental coronavirus vaccine by the end of the year, while maintaining its goal of readying 500…

Read More Here

How drugmakers can keep their pledge and still deliver an October vaccine surprise

As questions mount over whether the United States will authorize a coronavirus vaccine ahead of November elections, experts say there is a slim chance that enough evidence will be available…

Read More Here

Only one in 10 to be protected from COVID-19 in first year of vaccine use

Sky News on Sunday reported that just one in 10 of the world's population is likely to be protected against COVID-19 in the first year of a vaccine being made…

Read More Here

AstraZeneca says COVID-19 vaccine trial in U.S still on hold

AstraZeneca Plc said that its COVID-19 vaccine trial in the United States is still on hold. AstraZeneca on Saturday published a document describing details of how the COVID-19 vaccine trial…

Read More Here

Hungary’s economy hinges on vaccine discovery

Hungary's economy will struggle to grow next year if a coronavirus vaccine is not found, finance minister Mihaly Varga said in an interview published Saturday, as the government prepares to…

Read More Here